ArticleBiomarker research2026

The NFIL3-MYC signaling axis: a novel therapeutic target and prognostic marker in high-risk multiple myeloma.

Daniela Simone Maichl et al.PubMed ↗Publisher ↗

No numbers read from the abstract.